The data shows the payer share of Medicare Part D in retail prescriptions in 2017, by therapy area. In that year, Medicare Part D covered 39% within the therapy area of acute coronary syndrome (ACS) prescription drugs.
ACS | 39 |
AMI | 36.7 |
Asthma | 22.2 |
Breast Cancer | 25.1 |
Cholesterol | 38.6 |
Depression | 23.8 |
Diabetes | 33.9 |
Hypertension | 36.9 |
Multiple Sclerosis | 37.5 |
Osteoarthritis | 22.9 |
Prostate cancer | 20.3 |
Rheumatoid arthritis | 21.7 |